Yüklüyor......
PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
(1) Background: Niraparib and Talazoparib are poly (ADP-ribose) polymerase (PARP) 1/2 inhibitors. It is assumed that combining PARP inhibitors with radiotherapy could be beneficial for cancer treatment. In this study, melanoma cells were treated with Niraparib and Talazoparib in combination with ion...
Kaydedildi:
| Yayımlandı: | Genes (Basel) |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8229922/ https://ncbi.nlm.nih.gov/pubmed/34073147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12060849 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|